Patents
Patents for C07C 307 - Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (1,726)
01/2008
01/17/2008US20080015180 Methods and compositions for treating amyloid-related diseases
01/17/2008CA2658097A1 Pentadienamide derivatives
12/2007
12/27/2007US20070297941 Carbonylsulfamide and carbonylsulfoxamide derivatives; producing organic sterilizing agents when combined with percarbonate or perborate compound in aqueous medium; disinfecting medical equipment, air conditioner interiors, foodstuffs, plants, animal enclosures
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/13/2007US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007US20070286789 Method for Producing Chlorosulfonyl Isocyanate
12/11/2007US7307191 Organic peroxyacid precursors
11/2007
11/20/2007US7297816 2-(Benzo[1,2,5]thiadiazole-4-sulfonylamino)-4-chloro-N-methyl-N-(2-pyridin-2-yl-ethyl)-benzamide hydrochloride; cholecystokinin (CCK) receptor ligand inhibitors
11/08/2007WO2007050980A3 Process for preparing mesylate salts of il-12 inhibitory compounds
10/2007
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/30/2007US7288571 Thyroid receptor ligands and method II
10/25/2007WO2007118817A1 Coupling compounds and hair dyeing compositions containing them
10/25/2007US20070249702 Calcilytic compounds
10/24/2007EP1847528A1 Coupling compounds and hair dyeing compositions containing them
10/18/2007WO2007057849B1 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
10/17/2007EP1742909A4 Anionic-sweetener-based ionic liquids and methods of use thereof
10/16/2007US7282606 Process for preparation of tamsulosin and its aralkylamine derivatives
10/16/2007CA2209229C Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/03/2007EP1183232B1 Monofluoroalkyl derivatives
09/2007
09/25/2007CA2415551C Aniline derivatives
09/19/2007EP1622867B1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
09/18/2007US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/12/2007CN101035523A Optically enhanced chiral ionic liquids
09/11/2007CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
09/07/2007WO2007057849A3 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
08/2007
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/14/2007US7256215 Crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
08/14/2007US7256192 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
08/02/2007WO2007085469A1 Acyclic sulfamide derivatives
08/02/2007US20070179183 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
08/02/2007CA2640141A1 Acyclic sulfamide derivatives
07/2007
07/31/2007US7250447 Acylsulfamide inhibitors of factor VIIa
07/17/2007US7244845 Silylating a heterocyclic carboxylic acid, then chlorination, then sulfonation, to produce (R)-2-(4'-isopropoxycarbonylaminobiphenyl-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; matrix metalloproteinase inhibitors
07/17/2007US7244764 Methods and compositions for treating amyloid-related diseases
07/05/2007US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
07/03/2007CA2252465C Urea derivatives as inhibitors of impdh enzyme
06/2007
06/27/2007CN1989111A Method for the production of 3-phenyl(thio)uracils and dithiouracils
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/19/2007US7232929 Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
06/19/2007US7232926 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative
06/19/2007US7232817 α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors
06/19/2007CA2221014C New family of monomeric or polymeric photoinitiators in which sulfonic groups are fso2 groups
06/14/2007US20070135490 Phenetanolamine derivatives
06/12/2007US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties
05/2007
05/30/2007CN1972907A Sulfonamide compound
05/24/2007WO2007057849A2 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
05/23/2007EP1392620B1 Novel use of sulfamic acids as resolving agent.
05/22/2007US7220783 Para-terphenyl compounds
05/16/2007CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof
05/15/2007US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
05/15/2007US7217492 Onium salt compound and radiation-sensitive resin composition
05/08/2007US7214824 useful for the treatment of pain, neuralgia, neuropathies, nerve injury, burns, migraine, carpal tunnel syndrome, fibromyalgia, neuritis, sciatica, pelvic hypersensitivity, bladder disease, inflammation, or the like in mammals, especially humans
05/03/2007CA2627096A1 Process for preparing mesylate salts of il-12 inhibitory compounds
04/2007
04/26/2007WO2007017511A3 Compounds for treating alzheimer's disease
04/24/2007US7208524 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
04/18/2007EP1773787A1 Method for the production of 3-phenyl(thio)uracils and dithiouracils
04/18/2007EP1773762A2 Methods and compounds for detection of medical disorders
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/11/2007EP1207868B1 Pharmaceutical tramadol salts
04/10/2007US7202258 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/05/2007WO2006017148A3 Optically enhanced chiral ionic liquids
04/04/2007CN1308297C Phenyl sulfamate derivatives
04/03/2007US7199158 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
03/2007
03/28/2007EP1765781A2 Optically enhanced chiral ionic liquids
03/20/2007US7192606 carbocyclic imidodisulfamide compounds; preferably but not limited to infections caused by orthopox viruses
03/14/2007EP1762566A1 Branched surfactant having fluoroalkyl group and hydrocarbon group
03/14/2007CN1304372C Tri-substituted phenyl derivates useful as PDE IV inhibitors
03/07/2007EP1760073A1 Sulfonamide compound
02/2007
02/15/2007WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease
02/15/2007US20070037814 ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa
02/15/2007CA2618481A1 Compounds for treating alzheimer's disease
02/15/2007CA2618013A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease
01/2007
01/25/2007WO2007009354A1 Pyrrolidine derivative intermediates,preparation and usage thereof
01/23/2007US7166593 Glucocorticoid receptor modulators
01/18/2007WO2006091870A3 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
01/17/2007EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof
01/10/2007CN1894205A Method for producing chlorosulfonyl isocyanate
01/09/2007US7161031 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
12/2006
12/27/2006EP1736467A1 Novel sulfonamide derivative
12/27/2006CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups
12/21/2006WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006US20060287539 Chemical intermediates for production of sibutramine
12/07/2006WO2006006156A3 Compounds/methods for detection of medical disorders
11/2006
11/30/2006WO2006127184A1 Process for preparation of sulfamide derivatives
11/30/2006US20060270738 Novel derivatives of 3,3-diphenylpropylamines
11/30/2006CA2609185A1 Process for preparation of sulfamide derivatives
11/21/2006US7138418 Pentafluorobenzenesulfonamides and analogs
11/21/2006US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/14/2006US7135502 Colchinol derivatives as vascular damaging agents
11/14/2006US7135487 Sulphonamide derivatives
11/09/2006US20060252813 Apparatus for curing a composite laminate
11/07/2006CA2158268C N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
10/2006
10/31/2006US7129378 Method of preparing amine stereoisomers
10/11/2006EP1709155A2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
10/05/2006WO2005065361A3 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 18